These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2109426)

  • 21. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
    Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
    Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented survival of purified islet xeno- and allografts with reduced numbers.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654
    [No Abstract]   [Full Text] [Related]  

  • 23. DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival.
    Hullett DA; Landry AS; Eckhoff DE; Nichols JC; Eugui EM; Allison AC; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):756-7. PubMed ID: 8438470
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene expression profiling of allogeneic islet grafts in an experimental mouse model before rejection or tolerance phenotypes arise.
    Choi SE; Noh JR; Seo J; Yang KJ; Kook MC; Lee CH
    Transplant Proc; 2013 Mar; 45(2):597-604. PubMed ID: 23498796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral tolerance and allografts: can multiple oral administrations of low doses of highly purified islets induce peripheral tolerance in pancreatic islet allografts?
    Senesi B; Curiale V; Lione L; Puddu A; Pedemonte A; Pastorino A; Viviani GL
    Transplant Proc; 1998 Mar; 30(2):545-9. PubMed ID: 9532171
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model.
    Kaufman DB; Rabe FL; Platt JL; Dunn DL; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):857-8. PubMed ID: 2109421
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okazaki H; Taguchi Y; Mori S
    Transplant Proc; 1993 Feb; 25(1 Pt 2):971-2. PubMed ID: 8442285
    [No Abstract]   [Full Text] [Related]  

  • 28. Islet allografts: rejection and tolerance induction.
    Turvey SE; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):645. PubMed ID: 10083277
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerance induction in adult animals: comparison of RS-61443 and anti-CD4 treatment.
    Coulombe M; Hao L; Calcinaro F; Gill RG; Eugui EM; Allison AC; Lafferty KJ
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):31-2. PubMed ID: 2063419
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
    Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
    Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of experimental islet transplantation.
    Lafferty KJ; Prowse SJ; Simeonovic CJ; Hegre O; Chase HP
    Transplant Proc; 1984 Jun; 16(3):813-9. PubMed ID: 6428005
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of cryopreservation on islet recovery and in vivo function.
    Cattral MS; Lakey JR; Warnock GL; Kneteman NM; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3336. PubMed ID: 8539978
    [No Abstract]   [Full Text] [Related]  

  • 34. Xenotransplantation of UV-B irradiated islets.
    Rossi M; Dellagiacoma G; Marrazzo T; Tessitore N; Radin S
    Transplant Proc; 1992 Apr; 24(2):656-7. PubMed ID: 1566468
    [No Abstract]   [Full Text] [Related]  

  • 35. Abrogation of mouse pancreatic islet allograft rejection by a four-day culture.
    La Rosa FG
    Transplantation; 1988 Aug; 46(2):330-3. PubMed ID: 3136563
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
    Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
    Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
    [No Abstract]   [Full Text] [Related]  

  • 39. Islet allograft rejection is independent of toll-like receptor signaling in mice.
    Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
    Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor beta prevents islet allograft rejection.
    Gill RG
    Transplant Proc; 1991 Feb; 23(1 Pt 1):747-8. PubMed ID: 1990676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.